ArticleJournal of hepatology2021

Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.

Jessie Torgersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.